TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses
Citations Over TimeTop 10% of 2015 papers
Abstract
Autoantibodies induce various autoimmune diseases, including systemic lupus erythematosus (SLE). We previously described that CD4(+)CD25(-)LAG3(+) regulatory T cells (LAG3(+) Treg) are regulated by Egr2, a zinc-finger transcription factor required for the induction of T-cell anergy. We herein demonstrate that LAG3(+) Treg produce high amounts of TGF-β3 in an Egr2- and Fas-dependent manner. LAG3(+) Treg require TGF-β3 to suppress B-cell responses in a murine model of lupus. Moreover, TGF-β3- and LAG3(+) Treg-mediated suppression requires PD-1 expression on B cells. We also show that TGF-β3-expressing human LAG3(+) Treg suppress antibody production and that SLE patients exhibit decreased frequencies of LAG3(+) Treg. These results clarify the mechanism of B-cell regulation and suggest therapeutic strategies.
Related Papers
- → Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling(2008)68 cited
- → Effect of Transforming Growth Factor-beta (TGF-β) on Mammary Development(2003)11 cited
- → Short-or long-term effects of a low-protein diet on fibronectin and transforming growth factor-β synthesis in Adriamycin-induced nephropathy(アドリアマイシン腎症における短期および長期の低蛋白食投与の効果 -フィブロネクチンおよびtransforming growth factor(TGF)-β産生について)(1997)
- The Progress in Researches on TGF-β and its Receptor in Marfan Syndrome(2008)
- Transforming growth factor type beta(TGF—β1 )can increase IL—2R expression and suppress the proliferation of immature(CD~(4-)CD~(8-))thymocytes(1992)